Goldberg said the company "melded" a CBS News Sunday Mornings appearance from her to sell “bad weight loss drugs." ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

US President-elect Donald Trump has launched his own cryptocurrency, which quickly soared in value. His release of the meme coin, $Trump, comes as he prepares to take ...

For today we have 51 of the funniest new memes found anywhere on the entire Internet lined up for you all. This is the good stuff, all of Thursday’s absolute best memes right here in one place for you ...

The latest to join the ranks is the so-called “natural Mounjaro” drink for weight loss. Recipes vary slightly depending on which one you find, but the natural Mounjaro drink generally consists of ...

XRP surged to $3, its highest price since 2018, driving renewed interest in the XRP Ledger and meme coins. Meme coins like ARMY and PHNIX saw significant gains, with ARMY reaching a $107M market cap ...

The company's Q4 GLP-1 revenue is anticipated to be approximately $3.5 billion for Mounjaro and $1.9 billion for Zepbound, marking a 19% and 13% decrease from consensus predictions, respectively.

Today it’s a powerhouse, a finely tuned machine churning out memes, jokes, fashion trends, news, music, slang, and so much more faster than any modern social platform.

Wednesday is here and for today we have 51 of the funniest memes that have made their way to the Internet so far this week. This week seems to be flying by around here and that’s thanks in no small ...

The company attributed the revision to lower-than-expected sales of tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity. “It’s always disappointing to miss your own ...

This figure is $400 million below the low end of the company’s prior guidance and includes $3.5 billion from its type 2 diabetes drug Mounjaro and $1.9 billion from its weight-loss medication ...